The Impact of Soft Contact Lenses on the Corneal Neuromediators and Optical Quality in High Myopia Prior to SMILE
1 other identifier
observational
80
1 country
1
Brief Summary
To investigate the influence of Neuromediators expression in corneal stromal lenticules and corneal injury repair after small incision extraction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2024
CompletedStudy Start
First participant enrolled
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
October 21, 2024
October 1, 2024
1.7 years
October 16, 2024
October 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corneal stromal lenticule Neuromediators
Corneal neuromediators, including NGF(pg/mL), CGRP(pg/mL), SP(pg/mL), IGFBP-1(ng/mL), and MANF(pg/mL), which play pivotal roles in maintaining normal physiological functions of the cornea.
baseline
Secondary Outcomes (2)
Corneal Aberration
baseline
Corneal Densitometry
baseline
Study Arms (3)
SCLs >10 years
high myopia patients who wear SCL more than 10 years before Small Incision Lenticule Extraction
SCLs ≤10 years
high myopia patients who wear SCL for 10 years or less before Small Incision Lenticule Extraction
NW
high myopia patients who have not worn SCLs before Small Incision Lenticule Extraction
Interventions
This study does not involve any interventions
Eligibility Criteria
patients with high myopia who underwent SMILE surgery at Shanghai Tenth People's Hospital in Shanghai, China, between October 2020 and October 2023.
You may qualify if:
- age ≥ 18 years with stable refraction for at least two years;
- spherical equivalent (SE) \< -6.00 D;
- corrected distance visual acuity of 20/20 or better;
- no history of using rigid gas permeable lenses or orthokeratology (OK) lenses prior to examination
You may not qualify if:
- \- a history of moderate to severe dry eye as well as any ocular or systemic disease that would contraindicate laser refractive surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- yuhao shaolead
Study Sites (1)
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Biospecimen
All samples were collected from participants with high myopia who underwent SMILE surgery. The VisuMax femtosecond laser system (Carl Zeiss Meditec, Jena, Germany) was utilized with the following settings: a repetition rate of 500 kHz, pulse energy of 150 nJ, intended cap thickness of 110-120 μm, and optical zone of 6.0-6.8 mm. A circumferential incision width of 2 mm was made for lenticule dissection and extraction. The surgical procedures were performed by a single experienced surgeon (Dr. Zou). Following the SMILE surgeries, corneal stromal lenticules were transferred to Eppendorf tubes and stored at -80°C. for subsequent analysis.
Central Study Contacts
Yuhao Shao, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 16, 2024
First Posted
October 21, 2024
Study Start
October 18, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
October 21, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share